Literature DB >> 367433

Ocular and cardiovascular effects of local and systemic pindolol.

S E Smith, S A Smith, F Reynolds, V B Whitmarsh.   

Abstract

Ocular and cardiovascular effects of topical and intravenous pindolol have been studied in a balanced cross-0ver double-blind trial in 6 healthy volunteers. When applied to 1 eye pindolol lowered intraocular pressure in both the treated and untreated eyes with only minimal reduction in resting pupil diameter and light reflex response. The concentration in plasma was much lower and inhibiton of exercise tachycardia about half that when the same dose was administered intravenously. The findings suggest that beta-adrenoceptor blocking drugs should not be used in the treatment of glaucoma in patients who also suffer from heart failure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 367433      PMCID: PMC1043389          DOI: 10.1136/bjo.63.1.63

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  On the ophthalmotonic consensual reaction and its relationship to aqueous humor dynamics.

Authors:  E L PRIJOT; H H STONE
Journal:  Am J Ophthalmol       Date:  1956-07       Impact factor: 5.258

2.  The adrenergic receptors of the intraocular muscles in man. An in vitro study.

Authors:  R Kern
Journal:  Exp Eye Res       Date:  1971-01       Impact factor: 3.467

3.  A comparison of intravenous pindolol and propranolol in normal man.

Authors:  D C Hicks; A G Arbab; P Turner; M Hills
Journal:  J Clin Pharmacol New Drugs       Date:  1972 May-Jun

4.  Effect of pindolol on intraocular pressure.

Authors:  I Bonomi; P Steindler
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

5.  Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors.

Authors:  H H Harms
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

6.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

7.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

8.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15

9.  A comparison of some atropine-like drugs in man, with particular reference to their end-organ specificity.

Authors:  A HERXHEIMER
Journal:  Br J Pharmacol Chemother       Date:  1958-06

10.  Factors determining the potency of cholinomimetic miotic drugs and their effect upon the light reflex in man.

Authors:  S A Smith; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

View more
  10 in total

1.  Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.

Authors:  G E Trope; B Clark
Journal:  Br J Ophthalmol       Date:  1984-04       Impact factor: 4.638

2.  The consensual ophthalmotonic reaction.

Authors:  M V Gibbens
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

3.  Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol.

Authors:  S Andréasson; K M Jensen
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

4.  Beta adrenergic receptors in pigmented ciliary processes.

Authors:  G E Trope; B Clark
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

5.  Accidental dopamine in the eye.

Authors:  R Strauss
Journal:  West J Med       Date:  1985-03

6.  Local and systemic effects of pindolol eye drops.

Authors:  Q A Mekki; R Penhall; D F Edgar; J H Stewart-Jones; P Turner
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

7.  A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects.

Authors:  S Rowley; J E Staunton; A Tosch; J H Stewart-Jones; D F Edgar; P Turner
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

8.  Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.

Authors:  P J Bacon; D J Brazier; R Smith; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 9.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

10.  Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry.

Authors:  Shakoor Ba-Ali; Birgit Sander; Adam Elias Brøndsted; Henrik Lund-Andersen
Journal:  Front Neurol       Date:  2015-04-29       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.